Shared biological, psychological, and social pathways put patients at risk for both, whether obesity or depression occurs ...
The use of 42 mg lumateperone combined with antidepressant therapy was linked to significantly reduced severity of depression and anxiety, as well as greater response and remission rates, and was ...
WEDNESDAY, Sept. 10, 2025 (HealthDay News) -- A ketogenic diet (KD) is a feasible adjunctive therapy and is associated with improvements in depression symptoms among young adults with major depressive ...
A mechanism involving potassium channels in the brain that control brain cell activity could provide a new and fundamentally different way of treating depression symptoms in adults with major ...
BUFFALO, N.Y. — University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, ...
Mendelian randomization analysis of genome-wide association study data suggests schizophrenia and major depressive disorder may cause constipation. Constipation, a common and often debilitating ...
Patients who experienced a formulary-related rejection of cariprazine for adjunctive treatment of major depressive disorder had significantly higher hospitalization rates than those with approved ...
Statistically significantly effects were observed as early as week 1 and maintained throughout the study. Treatment with lumateperone significantly reduced depressive symptoms in patients with major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback